GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $467,090,000 | +215.5% | 10,730,254 | +215.6% | 2.39% | +291.6% |
| Q1 2022 | $148,070,000 | +87.8% | 3,400,013 | +90.1% | 0.61% | +106.8% |
| Q4 2021 | $78,830,000 | +571.1% | 1,788,114 | +481.3% | 0.30% | +555.6% |
| Q3 2021 | $11,747,000 | +45.6% | 307,622 | +51.8% | 0.04% | +50.0% |
| Q2 2021 | $8,067,000 | -86.1% | 202,594 | -87.5% | 0.03% | -86.7% |
| Q1 2021 | $57,942,000 | +18591.0% | 1,623,587 | +20493.4% | 0.22% | +22400.0% |
| Q1 2018 | $310,000 | -80.4% | 7,884 | -82.3% | 0.00% | -85.7% |
| Q4 2017 | $1,585,000 | +136.9% | 44,668 | +171.1% | 0.01% | +133.3% |
| Q3 2017 | $669,000 | +2473.1% | 16,476 | +2373.9% | 0.00% | – |
| Q4 2016 | $26,000 | -10.3% | 666 | 0.0% | 0.00% | – |
| Q3 2016 | $29,000 | -52.5% | 666 | -53.0% | 0.00% | – |
| Q2 2016 | $61,000 | -42.5% | 1,418 | -38.7% | 0.00% | -100.0% |
| Q3 2014 | $106,000 | -10.9% | 2,315 | +4.4% | 0.00% | 0.0% |
| Q2 2014 | $119,000 | – | 2,218 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |